Literature DB >> 10695020

Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.

K Yamada, T Tachibana, H Hashimoto, K Suzuki, S Yanagida, H Endoh, E Kimura, M Yasuda, T Tanaka, H Ishikawa.   

Abstract

The cell lines designated JHOS-2, JHOC-5 and JHOC-6 were established from epithelial ovarian carcinomas. JHOS-2 was established from a serous adenocarcinoma of a 45-year-old Japanese woman, JHOC-5 from a recurrent tumor of a clear cell adenocarcinoma of a 47-year-old Japanese woman and JHOC-6 from a tumor of a clear cell adenocarcinoma of a 43-year-old Japanese woman. These cell lines have grown well and serial passages were successively carried out more than 20 times. The monolayer cultured cells revealed neoplastic and pleomorphic features, and grew in multilayers. Electron micrographs revealed epithelial origins that had desmosomes and tonofilaments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695020

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  10 in total

1.  Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma.

Authors:  Daisuke Aoki; Nao Suzuki; Nobuyuki Susumu; Tomomi Noda; Atsushi Suzuki; Yutaka Tamada; Atsushi Higashiguchi; Shinji Oie; Shiro Nozawa
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

2.  Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Authors:  HanByoul Cho; Eun Suk Kang; Soon Won Hong; Youn Jin Oh; Sun Mi Choi; Sang Wun Kim; Sung Hoon Kim; Young Tae Kim; Kyoung Sun Lee; Yang Kyu Choi; Jae-Hoon Kim
Journal:  Mol Cell Biochem       Date:  2008-08-06       Impact factor: 3.396

3.  Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.

Authors:  Akihiro Ohyama; Junko Toyomura; Toshiaki Tachibana; Seiji Isonishi; Haruka Takahashi; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2016-08-19       Impact factor: 4.174

4.  Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.

Authors:  Peng Liu; Ashwani Khurana; Ramandeep Rattan; Xiaoping He; Steve Kalloger; Sean Dowdy; Blake Gilks; Viji Shridhar
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

5.  Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).

Authors:  Wei Jiang; Shuang Ye; Libing Xiang; Wentao Yang; Tiancong He; Xuan Pei; Lin Guo; Huijuan Yang
Journal:  J Ovarian Res       Date:  2018-07-09       Impact factor: 4.234

6.  Response to microtubule-interacting agents in primary epithelial ovarian cancer cells.

Authors:  Ilenia Pellicciotta; Chia-Ping Huang Yang; Charis A Venditti; Gary L Goldberg; Shohreh Shahabi
Journal:  Cancer Cell Int       Date:  2013-04-10       Impact factor: 5.722

7.  Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.

Authors:  Takashi Yamada; Kimiaki Hattori; Hidetoshi Satomi; Tadashi Okazaki; Hiroshi Mori; Yoshinobu Hirose
Journal:  J Ovarian Res       Date:  2016-06-04       Impact factor: 4.234

Review 8.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

9.  Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.

Authors:  Eniko Papp; Dorothy Hallberg; Gottfried E Konecny; Daniel C Bruhm; Vilmos Adleff; Michaël Noë; Ioannis Kagiampakis; Doreen Palsgrove; Dylan Conklin; Yasuto Kinose; James R White; Michael F Press; Ronny Drapkin; Hariharan Easwaran; Stephen B Baylin; Dennis Slamon; Victor E Velculescu; Robert B Scharpf
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

10.  TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.

Authors:  Ruth M Escalona; Maree Bilandzic; Patrick Western; Elif Kadife; George Kannourakis; Jock K Findlay; Nuzhat Ahmed
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.